Location History:
- Tsukuba, JP (2008)
- Ibaraki, JP (2005 - 2013)
- Moriya, JP (2009 - 2013)
Company Filing History:
7 out of 237 
7 out of 47 
2 out of 1,152 
Years Active: 2005-2013
Title: Innovator Nobuhiko Kawanishi: Pioneering Cancer Treatment Through Patent Innovations
Introduction
Nobuhiko Kawanishi is a notable inventor based in Moriya, Japan, recognized for his significant contributions to medical research and innovation. With an impressive portfolio of 14 patents, he has focused his efforts on developing compounds that seek to inhibit Akt activity, thereby offering potential treatments for cancer patients. His inventions showcase a blend of creativity, scientific knowledge, and a commitment to improving patient outcomes.
Latest Patents
Kawanishi's recent patents exemplify cutting-edge research in cancer treatment. His invention titled "Inhibitors of Akt activity" introduces substituted fused naphthyridine derivatives designed to inhibit the Akt signaling pathway. Specifically, these compounds selectively target one or two Akt isoforms, providing a targeted approach to cancer treatment. Another notable patent underlines the use of substituted [1,2,4]triazolo[4,3-a]-1,5-naphthyridine compounds, which primarily focus on inhibiting Akt1. Both inventions emphasize the development of compositions that could be administered to patients in need, marking a significant advancement in the field.
Career Highlights
Kawanishi has a distinguished career in the pharmaceutical industry, having worked with esteemed companies such as Banyu Pharmaceutical Co., Ltd. and MSD K.K. His professional background reflects his dedication to advancing medical research and his commitment to developing innovative therapies.
Collaborations
Throughout his career, Kawanishi has collaborated with talented individuals such as Takashi Mita and Mitsuru Ohkubo. These partnerships have undoubtedly contributed to the successful development of his patents and innovations, creating a valuable network that fosters creativity and scientific exploration.
Conclusion
Nobuhiko Kawanishi remains a pivotal figure in the realm of cancer research and therapeutics. With his extensive collection of patents and a strong foundation in pharmaceutical sciences, he is well-positioned to continue making impactful contributions to the medical field. As innovations unfold, Kawanishi's work promises to advance treatment options for patients worldwide, showcasing the vital role of inventors in shaping the future of healthcare.